𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: Pooled results from three countries

✍ Scribed by Michael E Jones, Flora E van Leeuwen, Wilhelmina E Hoogendoorn…

Book ID
120699067
Publisher
BioMed Central
Year
2012
Tongue
English
Weight
184 KB
Volume
14
Category
Article
ISSN
1465-5411

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Switching to exemestane after 2–3 years
Switching to exemestane after 2–3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen: Abstracted from: Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081–92.
✍ Christina Davies 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 248 KB